eldisine 5mg powder for solution for injection vials
genus pharmaceuticals ltd - vindesine sulfate - powder for solution for injection - 5mg
eldisine 5 mg inj. sol. (pwdr.) i.v. vial
eg sa-nv - vindesine sulfate 5 mg - powder for solution for injection - 5 mg - vindesine sulfate 5 mg - vindesine
eldisine vindesine sulfate 5mg powder for injection vial
aspen pharmacare australia pty ltd - vindesine sulfate, quantity: 5 mg - injection, powder for - excipient ingredients: mannitol - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) eldisine is indicated in the palliative treatment of the following: acute lymphocytic leukaemia of childhood resistant to other agents. blastic crises of chronic myeloid leukaemia in adults. non-small cell lung cancer. it should be noted that eldisine is usually given in combination with other oncolytic agents.
eldisine inj 5mg/2ml powder for solution
eli lilly canada inc - vindesine sulfate - powder for solution - 5mg - vindesine sulfate 5mg - antineoplastic agents
eldisine
eli lilly and company (nz) limited - vindesine sulfate 5mg; - powder for injection - 5 mg - active: vindesine sulfate 5mg
eldisine 5mg vial+solvent 5ml powder and solvent for solution for infusion
eli lilly and company - vindesine - powder and solvent for solution for infusion - 5 mg
fildesin injection 1mg (注射用フィルデシン1mg)
nichi-iko pharmaceutical co.,ltd - vindesine sulfate - injection
fildesin injection 3mg (注射用フィルデシン3mg)
nichi-iko pharmaceutical co.,ltd - vindesine sulfate - injection
dbl vinorelbine
hospira australia pty ltd - vinorelbine tartrate -
vinorelbine kabi
fresenius kabi australia pty limited - vinorelbine tartrate -